Joshua S. Boger, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 6,500 shares at $88.48 ($591K) on 2016-11-09, disclosed to the SEC on 2016-11-14.
Scheduled sale ($591k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $88.48 | 800 | $71K | 12.0% |
| 2 | $90.13 | 1,900 | $171K | 29.0% |
| 3 | $91.11 | 1,500 | $137K | 23.1% |
| 4 | $92.10 | 1,400 | $129K | 21.8% |
| 5 | $93.04 | 900 | $84K | 14.2% |
| Total | $90.98 avg | 6,500 |
| $591K |
| 100% |
| Filing → |
| VRTX | SELL | 2017-01-06 | $501K | — | Filing → |
| VRTX | SELL | 2017-01-03 | $483K | — | Filing → |
| VRTX | SELL | 2016-12-22 | $482K | — | Filing → |